ARTICLE | Distillery Therapeutics
Therapeutics: CD5 molecule-like (AIM; CD5L)
February 25, 2016 8:00 AM UTC
Cell culture and mouse studies suggest AIM could help treat acute kidney injury (AKI). In a mouse model of severe AKI, AIM decreased acute tubular necrosis and accumulation of intratubular debris in t...